Department of Biostatistics and Translational Medicine
Author : Jędrzej Chrzanowski
We are pleased to announce that Prof. Wojciech Fendler has been honored with the prestigious “ACHIEVEMENTS IN 2023” award at the 21st edition of the Golden OTIS Trust Award 2024! Prof. Fendler was recognized for his groundbreaking achievements in the field of medicine, which not only raise healthcare standards but also contribute to a better […]
We are happy to announce that the miRPOC project (“miRPOC: miRNA as biomarkers in early detection and personalised treatment in ovarian cancer”) has been awarded funding under the ERA PerMed Joint Translational Call 2022, co-financed by the European Commission. This project is conducted within an international research consortium and aims to develop and validate a […]
We are pleased to share a recent publication coauthored by Dr. Urszula Smyczyńska and Prof. Wojciech Fendler, entitled “Biological basis of extensive pleiotropy between blood traits and cancer risk.” The study offers valuable insights into the genetic basis of complex links between systemic immune cell levels and cancer susceptibility. The findings highlight genomic areas such […]
In recent days, Aleksander Rycerz, Eng., a sixth-year medical student pursuing an Individual Course of Study in our Department, visited the Cancer Research Institute in Cambridge, UK. During his stay at the Institute, he actively participated in research on the photoacoustic imaging of ovarian cancers dependent on endometriosis, led by Dr. Monika Golińska, PhD. Since […]
We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]
We are delighted to highlight the recent achievement of our team members: prof. Wojciech Fendler, together with his former PhD student – Beata Małachowska, MD, PhD, a current postdoc at the Department of Radiation Oncology in Albert Einstein College of Medicine (NYC, NY, USA). Their latest work, published in iScience, provides groundbreaking insights into the […]
Dr. Konrad Stawiski has been elected as a member of the international working group focusing on artificial intelligence in oncological radiotherapy within the European Society for Radiotherapy and Oncology. Dr. Konrad Stawiski’s term will last for 3 years. The task of the working groups is to assist in developing clinical and technical guidelines, provide advice […]
In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]
We are pleased to announce the recent grant success of our team! In the November results of the National Science Centre grant program OPUS 25, we have secured funding for the project “Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer”. The project was scored as the 2nd […]
We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from our team, titled “B cell depletion therapy to improve outcomes of steroid-sensitive nephrotic syndrome in adults – the BOOSTER trial,” has received funding recommendation in the second edition of the Medical Research Agency’s Head-to-Head Research […]
